F5, Inc. Form 144: 5,297 restricted shares flagged for sale

Rhea-AI Filing Summary

F5, Inc. filed a Form 144 notice indicating a proposed sale of 5,297 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 08/11/2025. The filing lists an aggregate market value of $1,706,874.03 and shows 57,447,170 shares outstanding, indicating the proposed sale is a small portion of the company's total shares.

The shares were acquired as restricted stock from the issuer on 08/01/2018 and payment is recorded as on that date. The filer reports no securities sold in the past three months and makes the standard representation that they do not possess undisclosed material information; the filing references Rule 10b5-1 language but does not provide a plan adoption date.

Insights

Securities Analyst

TL;DR: Small Rule 144 sale disclosed: 5,297 shares (~$1.71M) via Morgan Stanley; appears routine and not material to the float.

The Form 144 shows a planned sale of 5,297 common shares with an aggregate market value of $1,706,874.03, to be handled by Morgan Stanley Smith Barney LLC and listed for sale on NASDAQ on the stated approximate date. The filing confirms the shares were restricted stock acquired from the issuer on 08/01/2018 and that there were no sales in the past three months. From a market-impact perspective, the disclosure is factual and procedural; the filing itself contains no new financial results, guidance, or material changes to operations.

Corporate Governance Expert

TL;DR: Routine insider disclosure under Rule 144; includes issuer-acquired restricted stock and standard attestation on material nonpublic information.

The notice documents that the securities were originally issued as restricted stock by the issuer and purchased on 08/01/2018. The filer signs the standard attestation regarding knowledge of material nonpublic information and references Rule 10b5-1 language without specifying a plan date. This filing meets procedural disclosure obligations; no governance breach or compliance exception is identified within the text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5297	1706874.03	57447170	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2018	Restricted Stock	ISSUER			5297	08/01/2018	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did F5, Inc. (FFIV) report on Form 144?

The filing notifies a proposed sale of 5,297 common shares through Morgan Stanley Smith Barney LLC to be sold on NASDAQ with an approximate sale date of 08/11/2025.

What is the aggregate market value of the shares in the FFIV Form 144?

The aggregate market value listed in the notice is $1,706,874.03 for the 5,297 shares to be sold.

When and how were the shares being sold acquired according to the filing?

The filing states the shares were acquired as restricted stock from the issuer on 08/01/2018, with payment recorded on that same date.

Has the filer sold any securities of the issuer in the past three months?

The Form 144 lists Nothing to Report under securities sold during the past three months.

Does the filing indicate the filer has undisclosed material information or a 10b5-1 plan date?

The filer represents they do not know any material adverse information not publicly disclosed and references Rule 10b5-1 language, but no plan adoption date is provided in the text.